Friday, 6 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Rekvina Laboratories Merger & Restructuring Worth ₹5.09 Cr

Rekvina Laboratories allotted 50,87,750 equity shares on a preferential basis, aggregating ₹5.09 Crore, to acquire Radiant Parenterals Limited as a wholly-owned subsidiary.

Key figures
Value₹5.09 Cr
Source

BSE filing, NSE: VINRKLB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Rekvina Laboratories Ltd: key numbers

Share price
₹61.03
Market cap
₹36.79 Cr
Revenue (annual)
₹1.27 Cr
Net profit (annual)
₹-0.25 Cr
P/E (TTM)
-108.3×Sector 42.0×
Promoter holding
77.00%+35.70% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Rekvina Laboratories Ltd

All →

Other merger & restructuring announcements

All →